Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/28/2013 | CN102764274B Method for extracting propolis |
08/28/2013 | CN102698041B Traditional Chinese medicine compound gel for externally treating cancer pain and preparation method for same |
08/28/2013 | CN102670659B Cicada slough compound anti-inflammatory and analgesic extract and preparation process thereof |
08/28/2013 | CN102631498B Chinese medicinal composition |
08/28/2013 | CN102600476B Preparation method and application of drug-carrying keratin film |
08/28/2013 | CN102580027B Traditional Chinese medicine bag for treating vertebral artery cervical spondylosis and nursing method using same |
08/28/2013 | CN102579860B Child medicament extract composition and preparation method and application thereof |
08/28/2013 | CN102552539B Chinese medicinal composition for strengthening bone |
08/28/2013 | CN102552509B Traditional Chinese medicine combination for reducing heat and relieving cough |
08/28/2013 | CN102526279B Chinese medicinal composition for treating central high fever caused by acute cerebrovascular disease and preparation method for Chinese medicinal composition |
08/28/2013 | CN102526265B Chinese herbal preparation for treating vaginitis and preparation method thereof |
08/28/2013 | CN102525896B Pharmaceutical composition of lappaconitine hydrobromide |
08/28/2013 | CN102512552B Traditional Chinese medicine composition for treating exogenous fever |
08/28/2013 | CN102512452B Process method for preparing sea cucumber glycosides by using sea cucumber coelomic fluid |
08/28/2013 | CN102488720B Preparation method for submicron pine needle powder at normal temperature and special bidirectional air-flow screening machine |
08/28/2013 | CN102430090B Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof |
08/28/2013 | CN102250243B Antibody to interleukins-15 |
08/28/2013 | CN102234249B N-(hexahydropyrimidine-1,3-diyl)-di-L-amino acid methyl ester, preparation method thereof and application thereof |
08/28/2013 | CN102204951B Method for extracting active components from licorice |
08/28/2013 | CN102188550B Topical preparation for treating tendon and bone injuries |
08/28/2013 | CN102123986B Pharmaceutical compositions |
08/28/2013 | CN101732290B Stable solid formulation of egualen sodium |
08/28/2013 | CN101553456B Crystalline potassium salt of lipoxin A4 analogs |
08/28/2013 | CN101300259B Tricyclic spiro derivatives as CRTH2 modulators |
08/27/2013 | US8519183 Uses for amino acid anticonvulsants |
08/27/2013 | US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
08/27/2013 | US8518999 Modulators of TNF-αsignaling |
08/27/2013 | US8518995 Methods and compositions for the treatment of irritable bowel syndrome |
08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
08/27/2013 | US8518950 2-amido pyrazines for inflammation and immune related uses |
08/27/2013 | US8518913 Phosphorous derivatives as chemokine receptor modulators |
08/27/2013 | US8518460 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
08/27/2013 | US8518416 Compositions and methods for treatment of microbial infections |
08/27/2013 | CA2657776C Triazolyl phenyl benzenesulfonamides |
08/27/2013 | CA2566210C Oxo-substituted cyclohexyl-1,4-diamine derivatives |
08/27/2013 | CA2518774C Heterocyclic n-aryl carboxamides as cytokine inhibitors |
08/22/2013 | WO2013123432A2 Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
08/22/2013 | WO2013123335A1 Peripherally restricted diphenyl purine derivatives |
08/22/2013 | WO2013122897A1 Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors |
08/22/2013 | WO2013122559A1 Composition and methods for quenching free radicals and modulating inflammation |
08/22/2013 | WO2013121449A1 Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases |
08/22/2013 | WO2013121034A1 Methods and pharmaceutical compositions for reducing adipose tissue inflammation |
08/22/2013 | WO2013120896A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (pde4) |
08/22/2013 | WO2013101911A3 Benzimidazole derivatives as selective blockers of persistent sodium current |
08/22/2013 | WO2013100718A3 Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient |
08/22/2013 | US20130217771 Resolvins: bioemplates for novel therapeutic interventions |
08/22/2013 | US20130217723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory Agent |
08/22/2013 | US20130216585 Composition and methods for quenching free radicals and modulating inflammation |
08/22/2013 | US20130216574 Kit providing multiple unmet therapeutic effects |
08/22/2013 | US20130216502 Methods of Treating Intestinal Injury Using Heparin Binding Epidermal Growth Factor and Stem Cells |
08/22/2013 | CA2850380A1 Agents and method for treating inflammation-related conditions and diseases |
08/21/2013 | EP2627649A1 Cxcr4 receptor antagonists |
08/21/2013 | EP2627350A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders |
08/21/2013 | EP2627327A1 Novel triterpene derivatives |
08/21/2013 | CN203139401U Waist protection physiotherapy enclosing tool |
08/21/2013 | CN203139147U Self-conformal anti-seepage mirabilite paste |
08/21/2013 | CN203138934U Magnetic health-care mattress for treating osphyalgia, leg pain and bedsore |
08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
08/21/2013 | CN103261399A Composition for preventing inflammations |
08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
08/21/2013 | CN103261201A 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
08/21/2013 | CN103261194A Oxazolyl-methylether derivatives as ALX receptor agonists |
08/21/2013 | CN103261189A Amino-pyrrolidine-zetidine diamides as monoacylglycerol lipase inhibitors |
08/21/2013 | CN103261162A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid |
08/21/2013 | CN103260703A Piperidin-4-yl-zetidine diamides as monoacylglycerol lipase inhibitors |
08/21/2013 | CN103260702A A sustained release formulation of a non-steroidal anti-inflammatory drug |
08/21/2013 | CN103260629A Composition for use in treating and preventing inflammation related disorder |
08/21/2013 | CN103260613A 3-methanesulfonylpropionitrile for treating inflammation and pain |
08/21/2013 | CN103257189A (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
08/21/2013 | CN103254310A Improved antibody molecules |
08/21/2013 | CN103254292A Tyrosine kinase tyrosine polypeptideinhibitor of vascular endothelial growth factor receptor 2 and application thereof |
08/21/2013 | CN103254291A Tumor necrosis factor-alpha polypeptide inhibitors and application thereof |
08/21/2013 | CN103254290A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
08/21/2013 | CN103254267A Novel forms of cddo methyl ester |
08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
08/21/2013 | CN103254151A Benzisoxa thiazoles 5-LOX and mPGES-1 inhibitor and application |
08/21/2013 | CN103254086A Aromatic ester 5-LOX and mPGES-1 inhibitor and application |
08/21/2013 | CN103254081A Cancer pain therapeutic drug |
08/21/2013 | CN103254080A Pain therapeutic drug |
08/21/2013 | CN103254079A Compounds for treating cancer pains |
08/21/2013 | CN103254078A Cancer pain drug |
08/21/2013 | CN103254077A Pain disease therapeutic agent |
08/21/2013 | CN103254075A Preparation method of flurbiprofen axetil |
08/21/2013 | CN103251956A Matrine-montmorillonite nano composite and preparation method thereof |
08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
08/21/2013 | CN103251937A Medicaments and methods for treating headache |
08/21/2013 | CN103251924A Traditional Chinese medicine for assisting moxibustion in treating primary dysmenorrhea |
08/21/2013 | CN103251922A Pharmaceutical composition for treating limpness, numbness and crymodynia of limbs, and preparation method, preparation and application thereof |
08/21/2013 | CN103251914A Medicament for treating rheumatoid bone diseases |
08/21/2013 | CN103251911A Compound Uighur medicine preparation and application thereof |
08/21/2013 | CN103251910A Preparation method of compound Uighur medicine preparation |
08/21/2013 | CN103251900A Drug for treating dysmenorrhea |
08/21/2013 | CN103251899A Oral drug for treating dysmenorrhea |
08/21/2013 | CN103251898A Traditional Chinese medicine preparation for treating dysmenorrhea |